Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenomics of APAP Induced DILI in Chinese Population.

NCT04964310 is registered in ClinicalTrials.gov with The First Affiliated Hospital with Nanjing Medical University as lead sponsor.

NCT NCT04964310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04964310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenomics of APAP Induced DILI in Chinese Population.
Lead sponsor
The First Affiliated Hospital with Nanjing Medical University
Phase
Observational
Overall status
Recruiting
Start date
August 31, 2020
Completion date
December 31, 2026
Enrollment
339 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acetaminophen, china, drug-induced liver injury, pharmacogenetics